top of page

SAQUIN SR PROLONGED-RELEASE TABLETS 300MG

Product details

Registration number: SIN16692P

Classification: Prescription Only

Active ingredients: Quetiapine Fumarate eqv to Quetiapine

Strength: 300.000mg

Dosage form: TABLET, EXTENDED RELEASE

Route: ORAL

Registrant: MANSA HEALTHCARE PTE. LTD.

ATC code: N05AH04

HSA approval date: 14 February 2023

Manufacturer(s):

  • PHARMATHEN INTERNATIONAL S.A
  • PHARMATHEN S.A. (Primary and Secondary Packager)

Manufacturing country/countries: GREECE

What are the HSA registration number and classification for SAQUIN SR PROLONGED-RELEASE TABLETS 300MG?

According to the HSA dataset updated 7 August 2026:

Registration number: SIN16692P

Classification: Prescription Only

Source for this answer

What active ingredients and strength are recorded for SAQUIN SR PROLONGED-RELEASE TABLETS 300MG?

According to the HSA dataset updated 7 August 2026:

Active ingredients: Quetiapine Fumarate eqv to Quetiapine

Strength: 300.000mg

Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.

Source for this answer

What dosage form and route are recorded for SAQUIN SR PROLONGED-RELEASE TABLETS 300MG?

According to the HSA dataset updated 7 August 2026:

Dosage form: TABLET, EXTENDED RELEASE

Route: ORAL

Source for this answer

Who is the recorded registrant for SAQUIN SR PROLONGED-RELEASE TABLETS 300MG?

According to the HSA dataset updated 7 August 2026:

Registrant: MANSA HEALTHCARE PTE. LTD.

Source for this answer

Which manufacturers and countries are listed for SAQUIN SR PROLONGED-RELEASE TABLETS 300MG?

According to the HSA dataset updated 7 August 2026:

Manufacturer(s):

  • PHARMATHEN INTERNATIONAL S.A
  • PHARMATHEN S.A. (Primary and Secondary Packager)

Manufacturing country/countries: GREECE

Source for this answer

Where can I look up SAQUIN SR PROLONGED-RELEASE TABLETS 300MG in the HSA register?

Open HSA’s therapeutic product register and search for registration number SIN16692P or the exact product name SAQUIN SR PROLONGED-RELEASE TABLETS 300MG. The general register link does not preselect this product.

Source for this answer

What are the source dates for this SAQUIN SR PROLONGED-RELEASE TABLETS 300MG record?

This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.

The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.

Source for this answer

Has this SAQUIN SR PROLONGED-RELEASE TABLETS 300MG record had a separate HSA register check?

No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.

Search the HSA register using SIN16692P for the latest record.

Source for this answer

Sources and dates

HSA dataset: 2026. Updated: 13 November 2026.

Factual product information only; no dosing, treatment or suitability advice.

Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.

bottom of page